Delivery Order SPE2DB25D3404-SPE2DB25FUQAC
Award Date 8/25/25
Potential Completion Date 9/16/25
Potential Value $2.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for VYEPTI 100 mg/ml vials valued at $1,157.18 under a firm fixed price contract. The award, issued on August 7, 2025, with an ultimate completion date of August 28, 2025, represents a competitively awarded, non-set-aside procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $4,628.72 firm fixed price delivery order to AmerisourceBergen Drug Corp for VYEPTI 100 mg/mL vials, with an ultimate completion date of August 8, 2025. This non-set-aside contract was competitively awarded on July 18, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $20,829.24 to AmerisourceBergen Drug Corp for the supply of VYEPTI 100 MG/ML Vial on August 4, 2025, with an ultimate completion date of August 25, 2025. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under...
- The Defense Logistics Agency (DLA) awarded a $57,859.00 delivery order to AmerisourceBergen Drug Corp for VYEPTI 100 MG/ML Vial on August 7, 2025, with an ultimate completion date of August 28, 2025. This firm fixed-price contract, awarded without set-aside designation, represents a competitively awarded delivery order under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The...
- The Defense Logistics Agency awarded a $4,628.72 delivery order to AmerisourceBergen Drug Corp for VYEPTI (eptinezumab) 100 mg/ml vials, with performance at the contractor's Conshohocken, Pennsylvania location and an ultimate completion date of August 13, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- The Defense Logistics Agency awarded a $4,628.72 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Vyepti 100 mg/ml vials. This non-set-aside contract is scheduled for completion by August 12, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,471.54 for VYEPTI 100 mg/ml vials, with an ultimate completion date of August 12, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is listed as...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,628.72 to AmerisourceBergen Drug Corp for VYEPTI 100 mg/ml vials, with an ultimate completion date of August 18, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded through an open procurement process. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for VYEPTI 100 mg/mL vials valued at $3,471.54 on August 12, 2025, with completion targeted for September 3, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. The award will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. VYEPTI (eptinezumab) is a monoclonal antibody used for migraine prevention,...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide VYEPTI 100 MG/ML VIAL/ML pharmaceuticals. The $12,810.12 contract has a completion date of February 23, 2024. AmerisourceBergen Drug Corp, a for-profit organization, serves as the prime contractor and provides a wide range of pharmaceutical products and medical supplies to the Department of...